SCHEMBL7867896

SCHEMBL7867896

O=C(NCCO)Oc1ccc(C(=O)NS(=O)(=O)c2ccc(C(=O)NC3CCCCC3)cc2)cn1

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.49
TSHR P16473 3/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
CYP3A4 P08684 1/20 0.47
HTR1A P08908 1/20 0.47
MAPT P10636 1/20 0.47
CYP2C9 P11712 1/20 0.47
NFKB1 P19838 1/20 0.47
CNR1 P21554 1/20 0.47
CYP2C19 P33261 1/20 0.47
ADRA1A P35348 1/20 0.47
BLM P54132 1/20 0.47
HTT P42858 1/20 0.46
KMT2A Q03164 1/20 0.46
ALDH1A1 P00352 2/20 0.45
GAA P10253 1/20 0.45
GFER P55789 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7862846 0.91 LMNA (0.47) LMNATSHRSMN1; SMN2CYP3A4HTR1A
SCHEMBL7870547 0.90 HTT (0.48) HTTKMT2AALDH1A1GAA
SCHEMBL7867700 0.89 LMNA (0.45) LMNATSHRSMN1; SMN2CYP3A4HTR1A
SCHEMBL7870524 0.86 SMN1; SMN2 (0.46) LMNATSHRSMN1; SMN2MAPTHTT
SCHEMBL8868071 0.85 LMNA (0.55) LMNATSHRSMN1; SMN2CYP3A4HTR1A
SCHEMBL7862898 0.85 LMNA (0.47) LMNATSHRSMN1; SMN2CYP3A4HTR1A
SCHEMBL7870549 0.85 MAPT (0.47) LMNATSHRSMN1; SMN2CYP3A4HTR1A
SCHEMBL9018193 0.85 LMNA (0.53) LMNATSHRSMN1; SMN2BLMHTT
SCHEMBL7870571 0.84 EPHX2 (0.45) LMNATSHRSMN1; SMN2CYP3A4HTR1A
SCHEMBL7871681 0.84 EGFR (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0562512-B1 Sulfonamidocarbonylpyridine-2-carboxamides and their use as medicines HOECHST AG (DE) 2001-02-21 EP disclosed
EP-0562512-A1 Sulfonamido- and sulfonamidocarbonyl-pyridine-2-carboxamides and their pyridine-N-oxides, process for their preparation and their use as medicines HOECHST AKTIENGESELLSCHAFT (DE) 1993-09-29 EP disclosed